Abstract
Bei Autismus-Spektrum-Störungen (ASD) handelt es sich um komplexe Störungsbilder, die gerade im Kindesalter aufgrund der vielfältigen Differentialdiagnosen einer multidisziplinären und mehrschrittigen Diagnostik bedürfen. Eine Früherkennung autistischer Störungen ist ab dem zweiten Lebensjahr möglich. Standardisierte Verfahren verbessern die diagnostische Validität, erfordern jedoch eine fundierte kinder- und jugendpsychiatrische Expertise. Generell ist in der Behandlung ein ganzheitlicher, die Gesamtentwicklung des Kindes mit ASD umfassender Therapie- und Förderansatz zu verfolgen. Früh beginnende, intensive, verhaltenstherapeutische Interventionen unter Einbezug der Eltern haben sich als wirksam erwiesen. Die pharmakologische Behandlung von begleitenden Auffälligkeiten kann als ergänzende Maßnahme sinnvoll sein, da das Ansprechen auf pädagogische und psychotherapeutische Maßnahmen hierdurch verbessert werden kann.
Autism spectrum disorders (ASD) are complex syndromes and their diagnosis requires a multidisciplinary and step-by-step approach, especially in children due to the broad range of possible differential diagnoses. Early detection of autistic disorders is possible from the age of 2 on. The use of standardized procedures enhances the diagnostic validity, but demands profound child and adolescent psychiatric expertise. Generally, any treatment of a child with ASD should take a holistic view bearing in mind the child’s overall development. Intensive early-onset behavior therapeutic interventions involving the parents have proven effective. Complementary pharmaceutical treatment of accompanying conditions may be helpful as it may enhance educational and psychotherapeutic treatment response.
Literatur
2000). A screening instrument for autism at 18 months of age. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 694 – 702.
(2001). Current topic: Screening and surveillance for autism and pervasive developmental disorders. Archives of Disease in Childhood, 84, 468 – 475.
(2006). Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames. Lancet, 368, 210 – 215.
(2000). Early identification of autism by the Checklist for Autism in Toddlers (CHAT). Journal of the Royal Society of Medicine, 93, 521 – 525.
(2007). Brief report: Individual social-multi-modal intervention for HFASD. Journal of Autism and Developmental Disorders, 37, 1593 – 1604.
(2005). Bayley Scales of Infant and Toddler Development (3rd ed.). San Antonio: Pearson Assessment.
(2001). Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial. Journal of Autism and Developmental Disorders, 31, 175 – 181.
(2007). Kinder mit Autismus-Spektrum-Störungen. Stuttgart: Kohlhammer.
(2009). Special report: Early intensive behavioral intervention based on applied behavior analysis among children with autism spectrum disorders. Technology Evaluation Center Assessment Program Executive Summary, 23, 1 – 61.
(2006). Fragebogen zur Sozialen Kommunikation (FSK). Bern: Huber.
(2006). Diagnostisches Interview für Autismus–Revidiert (ADI-R). Bern: Huber.
(2007). Autism spectrum disorder in the second year: Stability and change in syndrome expression. Journal of Child Psychology and Psychiatry and Allied Disciplines, 48, 128 – 138.
(2007). Between a ROC and a hard place: Decision making and making decisions about using the SCQ. Journal of Child Psychology and Psychiatry and Allied Disciplines, 48, 932 – 940.
(2001). Comparisons of discrete-trial and normalized behavioral language intervention for young children with autism. Journal of Autism and Developmental Disorders, 31, 315 – 325.
(2007). Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter (3. überarb. Aufl.). Köln: Deutscher Ärzteverlag.
(2003). Parent-mediated early intervention for young children with autism spectrum disorder. Cochrane Database of Systematic Reviews, CD003496.
(2004). Methylphenidate for pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 14, 207 – 218.
(2006). Screening for autistic spectrum disorder in children aged 14 – 15 months. Journal of Autism and Developmental Disorders, 36, 713 – 722.
(2009). Neurologische, genetische und körperliche Untersuchung. In , Autismus. Spektrum, Ursachen, Diagnostik, Intervention, Perspektiven (S. 205 – 218). Bern: Huber.
(2005). Screening for autism in young children: The Modified Checklist for Autism in Toddlers (M-CHAT) and other measures. Mental Retardation and Developmental Disabilities Research Reviews, 11, 253 – 262.
(2009). Meta-analysis of early intensive behavioral intervention for children with autism. Journal of Clinical Child and Adolescent Psychology, 38, 439 – 450.
(2000). Practice parameter: Screening and diagnosis of autism: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology, 55, 468 – 479.
(2003). Epidemiological surveys of autism and other pervasive developmental disorders: An update. Journal of Autism and Developmental Disorders, 33, 365 – 382.
(2009). Diagnose und Therapie autistischer Störungen. Monatsschrift Kinderheilunde, 157, 1257 – 1264.
(2006). Music therapy for autistic spectrum disorder. Cochrane Database of Systematic Reviews, CD004381.
(2000). Sprachentwicklungstest für zweijährige Kinder (SETK-2). Göttingen: Hogrefe.
(2001). Sprachentwicklungstest für drei- bis fünfjährige Kinder (SETK 3 – 5). Göttingen: Hogrefe.
(2000). Age and IQ at intake as predictors of placement for young children with autism. Journal of Autism and Developmental Disorders, 30, 137 – 142.
(2005). Der TEACCH Ansatz zur Förderung von Menschen mit Autismus. Dortmund: verlag mondernes lernen.
(2003). SOKO Autismus. Dortmund: verlag modernes lernen.
(2009). Pilot evaluation of the Frankfurt Social Skills Training for children and adolescents with autism spectrum disorder. European Child and Adolescent Psychiatry, 18, 327 – 335.
(2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 30, 582 – 589.
(2006). A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology 16, 541 – 548
(2009). Systematic review of early intensive behavioral interventions for children with autism. American Journal on Intellectual and Developmental Disabilities, 114, 23 – 41.
(1995). A history of facilitated communication. American Psychologist, 50, 750 – 765.
(2010). Frühsymptome des Asperger-Syndroms im Kindesalter: Eine retrospektive Untersuchung. Kindheit und Entwicklung, 19, 168 – 176.
(1997). TEACCH-supported employment program. Journal of Autism and Developmental Disorders, 27, 3 – 9.
(2008). The modified checklist for autism in toddlers. Journal of Autism and Developmental Disorders, 38, 827 – 839.
(2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. Journal of Clinical Psychiatry, 67, 407 – 414.
(2003). The National Autism Plan. London: National Autistic Society.
(2008). Diagnosing autism spectrum disorders in pre-school children using two standardised assessment instruments: The ADI-R and the ADOS. Journal of Autism and Developmental Disorders, 38, 362 – 372.
(2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36, 849 – 861.
(1981). Teaching developmentally disabled children. Austin: Pro-Ed.
(2006). Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. Journal of Child and Adolescent Psychopharmacology, 16, 575 – 587.
(2008). A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders. Behavior Modification, 32, 61 – 76.
(2007). Social-skills treatments for children with autism spectrum disorders: An overview. Behavior Modification, 31, 682 – 707.
(2005). Safety issues with drug therapies for autism spectrum disorders. Journal of Clinical Psychiatry, 66, 32 – 37.
(2005). Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. American Journal of Psychiatry, 162, 1142 – 1148.
(2007). Evidence-based approaches to autism spectrum disorders. Child: Care, Health and Development, 33, 509 – 512.
(2007). Parent implemented early intervention for young children with autism spectrum disorder: A systematic review. Journal of Evaluation in Clinical Practice, 13, 120 – 129.
(2002). Interventions to facilitate social interaction for young children with autism: Review of available research and recommendations for educational intervention and future research. Journal of Autism and Developmental Disorders, 32, 351 – 372.
(2001). The use of the ADI-R as a diagnostic tool in the differential diagnosis of children with infantile autism and children with a receptive language disorder. European Child and Adolescent Psychiatry, 10, 248 – 255.
(2008). Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database of Systematic Reviews, CD003498.
(2001). Facilitated communication since 1995: A review of published studies. Journal of Autism and Developmental Disorders, 31, 287 – 313.
(2001). Incorporating social goals in the classroom. London: Jessica Kingsley.
(2003). Citalopram treatment of children and adolescents with obsessive-compulsive disorder: A preliminary report. Psychiatry and Clinical Neuroscience, 57, 405 – 408.
(2004). Autism Spectrum Disorders. Pervasive developmental disorders. With Addendum January 2007. Rockville, MD: National Institute of Mental Health.
(2008). Früherkennung von autistischen Störungen. Nervenheilkunde, 27, 38 – 39.
(2008). Behavioural and developmental interventions for autism spectrum disorder: A clinical systematic review. PLoS ONE, 3, 1 – 32.
(2002). Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Development and Psychopathology, 14, 239 – 251.
(2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124, 1533 – 1540.
(2005). An open-label trial of escitalopram in pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 343 – 348.
(2005). Parental report of the early development of children with regressive autism. Autism, 9, 461 – 486.
(2009). Wechsler Preschool and Primary Scale of Intelligence–Deutsche Version (WPPSI). Frankfurt: Pearson Assessment.
(2006). Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology 16, 599 – 610.
(2007). Neurobiology of autism. In Autism and pervasive developmental disorders (pp. 179 – 220). Cambridge: Cambridge University Press.
(2007). KONTAKT. Bern: Huber.
(2007). Psychopharmakologie autistischer Störungen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 35, 87 – 94.
(2009). A review of the efficacy of the picture exchange communication system intervention. Journal of Autism and Developmental Disorders, 39, 1471 – 1486.
(2003). Entwicklung und Evaluation eines psychoedukativen Elterngruppen-trainings für Familien mit autistischen Kindern. Praxis der Kinderpsychologie und Kinderpsychiatrie, 52, 473 – 490.
(2001). Review: Elterntrainings im Rahmen der Rehabilitation autistischer Kinder: Konzepte und Ergebnisse. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie, 49, 1 – 32.
(2008). Brief report: Outcomes of a teacher training program for autism spectrum disorders. Journal of Autism and Developmental Disorders, 38, 1791 – 1796.
(2008). Development of the evaluative method for evaluating and determining evidence-based practices in autism. Journal of Autism and Developmental Disorders, 38, 1311 – 1319.
(2009). Comprehensive synthesis of early intensive behavioral interventions for young children with autism based on the UCLA young autism project model. Journal of Autism and Developmental Disorders, 39, 23 – 41.
(2006). Asperger Syndrom. Heidelberg: Springer.
(2007). Das Asperger-Syndrom–eine Autismus-Spektrum-Störung. Deutsches Ärzteblatt, 104, 873 – 881.
(2008). Evidence-based comprehensive treatments for early autism. Journal of Clinical Child and Adolescent Psychology, 37, 8 – 38.
(2004). ADOS, Diagnostische Beobachtungsskala für Autistische Störungen. Bern: Huber.
(2003). Social Communication Questionnaire (SCQ). Los Angeles: Western Psychological Services.
(2006). Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: A retrospective and prospective effectiveness study. Child: Care, Health and Development, 32, 575 – 583.
(2008). Effects of augmentative and alternative communication intervention on speech production in children with autism: A systematic review. American Journal of Speech-Language Pathology, 17, 212 – 230.
(2009). Systematic reviews of psychosocial interventions for autism: An umbrella review. Developmental Medicine and Child Neurology, 51, 95 – 104.
(2006). Auditory integration training and other sound therapies for autism spectrum disorders: A systematic review. Archives of Disease in Childhood, 91, 1018 – 1022.
(2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 921 – 929.
(2007). Designing research studies on psychosocial interventions in autism. Journal of Autism and Developmental Disorders, 37, 354 – 366.
(2008). Sensitivity and specificity of the Modified Checklist for Autism in Toddlers and the Social Communication Questionnaire in preschoolers suspected of having pervasive developmental disorders. Autism, 12, 627 – 644.
(2008). The effectiveness of parent-child interaction therapy for families of children on the autism spectrum. Journal of Autism and Developmental Disorders, 38, 1767 – 1776.
(2008). Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 17, 753 – 771
(2009). Efficacy of applied behavioral intervention in preschool children with autism for improving cognitive, language, and adaptive behavior: A systematic review and meta-analysis. Journal of Pediatrics, 154, 338 – 344.
(2009). Aripiprazole in pervasive developmental disorder not otherwise specified and Aspergers disorder: A 14-week, prospective, open-label study. Journal of Child and Adolescent Psychopharmacology, 19, 265 – 274.
(2007). SON-R 2½–7. Non-verbaler Intelligenztest: Testmanual mit deutscher Normierung und Validierung. Göttingen: Hogrefe.
(2006). Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: A pilot study. Journal of Child and Adolescent Psychopharmacology, 16, 611 – 619.
(2009). Verhaltens- und fertigkeitenbasierte Frühinterventionen bei Kindern mit Autismus. Köln: DIMDI.
(2002). Autismus-Therapien im Vergleich. Berlin: Wissenschaftsverlag Spiess.
(2003). Pharmakotherapie von Zwangsstörungen im Kindes- und Jugendalter. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 31, 223 – 230.
(2007). Social skills development in children with autism spectrum disorders: A review of the intervention research. Journal of Autism and Developmental Disorders, 37, 1858 – 1868.
(